Last updated Nov 4, 2026
A 6-month-old Mediterranean infant presents with pallor and failure to thrive. Hemoglobin electrophoresis shows elevated HbF and HbA2. The child requires regular transfusions.
AR; HBB, encoding hemoglobin subunit beta. Variants abolish or reduce beta chain production, leaving alpha chains in excess.
- β0: No beta-globin production
- β+: Reduced beta-globin production
Types:
- Thalassemia major: Severe anemia, transfusion-dependent
- Thalassemia intermedia: Moderate anemia, variable transfusion needs
- Thalassemia minor (trait): Mild microcytic anemia, usually asymptomatic
Adult hemoglobin A is two alpha and two beta globin chains, and HBB encodes the beta chain. Severity depends on the imbalance between alpha chains and their partner chains (beta or gamma). Unpaired alpha chains precipitate as inclusions that damage red cell precursors in the marrow and spleen, causing ineffective erythropoiesis. The resulting dysregulation of iron metabolism raises intestinal iron absorption, which is why iron overload can develop even without regular transfusion.
- β0 alleles (no beta chain): nonsense, frameshift, and some splice variants. Two β0 alleles typically cause thalassemia major.
- β+ alleles (some beta chain): variants in introns, the promoter, the polyadenylation signal, the untranslated regions, or splicing. Two β+ alleles can cause intermedia or minor; some are mild or silent.
The globin switch explains the timing: infants without two β0 alleles may not be diagnosed until 6 to 12 months, when the change from gamma to beta globin exposes the defect. Anything that narrows the imbalance may make disease milder: coinherited alpha-thalassemia, or variants that sustain gamma globin (HbF) production (in HBG2, BCL11A, HBS1L-MYB). Extra alpha genes widen it, so one HBB variant plus an alpha globin duplication can cause intermedia.
- Severe anemia presenting after 6 months (fetal Hb decline)
- Hepatosplenomegaly (extramedullary hematopoiesis)
- Skeletal changes (frontal bossing, maxillary hypertrophy)
- Iron overload (from transfusions and increased absorption)
- Not a named RUSP condition, but often detected incidentally on newborn screening hemoglobin patterns (the RUSP core hemoglobinopathy targets are Hb S,S; Hb S,β-thalassemia; and Hb S,C)
- CBC shows microcytic, hypochromic anemia with normal iron studies (distinguishes from iron deficiency)
- Hemoglobin electrophoresis or HPLC: elevated HbA2 (>3.5%) is the hallmark of trait, with elevated HbF; major shows markedly reduced or absent HbA
- HBB sequencing confirms the diagnosis and identifies β0 vs β+ variants for prognosis
- Carrier screening and prenatal diagnosis indicated when both partners carry HBB variants
- Regular transfusions, iron chelation
- HSCT
- Gene therapy (betibeglogene autotemcel)
HbA2 is "Up in B diseases": In beta-globin disorders (beta-thalassemia, sickle cell, HbC disease), HbA2 is elevated. Remember: HbA2 is basically HbA (similar name), so it is preferentially made over HbF when beta-globin is mutated.
HbA2 (α2δ2) = 2nd in line to HbA (α2β2). HbA2 Composed of 2 alpha and two delta chains (α2δ2).
When beta-globin is not available to form HbA (because patients have a beta-globinopathy), HbA2 forms

The anemia classification tree organizes anemias by MCV into microcytic, normocytic, and macrocytic categories, with genetic causes highlighted in each group.
